Long COVID a Global Issue for Patients and Healthcare Systems Long COVID a Global Issue for Patients and Healthcare Systems
British researchers led by Oxford University said on Friday that the current understanding of long COVID and options to treat it is emerging as a major long-term issue for global healthcare systems after reviewing the illness ' effects on patients.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 18, 2022 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

WHO grants prequalification of Actemra/RoActemra for patients with severe or critical COVID-19
WHO ’s prequalification adds to several mechanisms already in place to improve access to Actemra/RoActemra for people with COVID-19 in low- and middle-income countriesSince the beginning of the pandemic, more than one million patients with severe COVID-19 have been treated with Actemra/RoActemra, as recommended in global treatment guidelinesTwelfth Roche medicine or test to be prequalified Basel, 11 February 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that Actemra ®/RoActemra® (tocilizumab) intravenous (IV) has been granted World Health Organization (WHO) prequalification. Prequalification is a confi...
Source: Roche Investor Update - February 11, 2022 Category: Pharmaceuticals Source Type: news

Coronavirus (COVID-19) Infection Survey, antibody and vaccination data, UK: 9 February 2022, ONS
This study is jointly led by the Office for National Statistics (ONS) and the Department for Health and Social Care (DHSC) working with the University of Oxford and Lighthouse Laboratory to collect and test samples. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - February 9, 2022 Category: Consumer Health News Source Type: news

Coronavirus (COVID-19) Infection Survey headline results, UK: 9 February 2022, ONS
This study is jointly led by the Office for National Statistics (ONS) and the Department for Health and Social Care (DHSC) working with the University of Oxford and Lighthouse laboratory to collect and test samples. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - February 9, 2022 Category: Consumer Health News Source Type: news

Using digital devices to soothe young children could mean they miss learning how to calm themselves
A new study, conducted by University of Oxford, has shown that using screens to soothe a toddler could also mean they miss out on learning how to calm themselves down. (Source: the Mail online | Health)
Source: the Mail online | Health - February 7, 2022 Category: Consumer Health News Source Type: news

New HIV strain found in the Netherlands: Highly infectious variant makes people ill twice as quick
Oxford University researchers found the new mutation - called the VB variant - has already infected 109 people, the vast majority of whom are in the Netherlands. (Source: the Mail online | Health)
Source: the Mail online | Health - February 4, 2022 Category: Consumer Health News Source Type: news

Coronavirus (COVID-19) Infection Survey headline results, UK: 2 February 2022, ONS
This study is jointly led by the ONS and the Department for Health and Social Care (DHSC) working with the University of Oxford and Lighthouse laboratory to collect and test samples. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - February 3, 2022 Category: Consumer Health News Source Type: news

Interview with authors of Hip Fracture reviews
In this interview, we learn more about a series of reviews on hip fractures published on the Cochrane Library and talk to some of the authors behind this work Prof Xavier Griffin and orthopaedic surgeons Mr William Eardley and Mr Martyn Parker.Tell us how did these reviews come about?This work was funded by the National Institute of Health Research Systematic Reviews programme, as a joint application from Oxford University andCochrane ’s Bone, Joint and Muscle Trauma Group. The underlying concept was that there is diverse, congested and complex literature of varying quality around hip fracture and it can be hard to inter...
Source: Cochrane News and Events - January 31, 2022 Category: Information Technology Authors: Lydia Parsonson Source Type: news

Coronavirus (COVID-19) Infection Survey headline results, UK: 26 January 2022, ONS
This study is jointly led by the ONS and the Department for Health and Social Care (DHSC) working with the University of Oxford and Lighthouse laboratory to collect and test samples. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 26, 2022 Category: Consumer Health News Source Type: news

The World ’s Largest Vaccine Manufacturer Stumbled in 2021. Its CEO Bets He Can Still Help End COVID-19
Adar Poonawalla is no stranger to gambles. He owes his multibillion-dollar empire to a series of big bets that paid off handsomely. Cyrus Poonawalla, his father, made his own fortune on horses—and then multiplied it by making another bet in 1966: that he could make more money producing vaccines than he could on horse breeding and racing. He formed the Serum Institute of India (SII), which grew slowly for three decades, selling antivenoms and lifesaving vaccines for India. When Adar, then just 21, joined the company in 2001, he persuaded his father to dramatically ramp up production—wagering that they could fill...
Source: TIME: Health - January 20, 2022 Category: Consumer Health News Authors: Abhishyant Kidangoor Tags: Uncategorized biztech2030 COVID-19 Davos feature Magazine overnight Special Project Source Type: news

Coronavirus (COVID-19) Infection Survey, UK: 31 December 2021, ONS
This study is jointly led by the ONS and the Department for Health and Social Care (DHSC) working with the University of Oxford and Lighthouse laboratory to collect and test samples. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - December 31, 2021 Category: Consumer Health News Source Type: news

Omicron Now Accounts for 59% of U.S. COVID-19 Cases, According to Public Health Officials
The Omicron variant is causing an increasing share of coronavirus infections in the U.S., though its climb to dominance has been gentler than earlier estimates indicated, according to an updated federal model. Omicron accounted for an estimated 58.6% of sequenced U.S. virus cases in the week ending Dec. 25, the Centers for Disease Control and Prevention’s Nowcast model showed Tuesday, up from an estimated 22.5% a week earlier. The once-dominant Delta variant accounted for 41.1% of cases in the most recent period, according to the CDC. Nowcast estimates levels of variant prevalence based on genomic-sequencing data. [t...
Source: TIME: Health - December 28, 2021 Category: Consumer Health News Authors: Angelica Peebles / Bloomberg Tags: Uncategorized bloomberg wire COVID-19 healthscienceclimate Source Type: news

Steps taken to target Omicron with AstraZeneca jab, scientist says
Sandy Douglas, from Oxford University, says updated vaccine could ‘respond to any new variant more rapidly’Coronavirus – latest updatesSee all our coronavirus coverageOxford and AstraZeneca have taken “preliminary steps” to produce an updated version of their coronavirus vaccine to specifically target the Omicron variant, a scientist at the university has said.Sandy Douglas, a research group leader at Oxford,told the Financial Times that an updated vaccine could be used to “respond to any new variant more rapidly” than previously believed.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - December 21, 2021 Category: Science Authors: L éonie Chao-Fong Tags: Coronavirus AstraZeneca University of Oxford Pharmaceuticals industry Infectious diseases Medical research UK news Source Type: news

Covid-19 Has Accelerated New Agtech Development and Adoption in Asia-Pacific!
By Paul S. Teng and Genevieve Donnellon-MaySINGAPORE, Dec 20 2021 (IPS) While the COVID-19 impact has been predominantly negative, the pandemic appears to have sparked increased interest in developing agricultural technology (agtech) to improve the efficiency of food systems, from input supplies through farming and processing to delivery and retail. Paul S. TengThe COVID-19 pandemic has admittedly upended economic activity in the Asia-Pacific region, but a recent event in Singapore (Asia-Pacific Agri-Food Innovation Summit, 16-18 November 2021 — https://agrifoodinnovation.com/ ) showed that, in the case of agricultu...
Source: IPS Inter Press Service - Health - December 20, 2021 Category: International Medicine & Public Health Authors: Paul S. Teng and Genevieve Donnellon-May Tags: Asia-Pacific COVID-19 Development & Aid Economy & Trade Environment Food and Agriculture Food Security and Nutrition Food Sustainability Headlines Health Humanitarian Emergencies TerraViva United Nations IPS UN Bureau Source Type: news